Ivermectin and Mebendazole: Cancer Research Claims

We just published the most comprehensive ivermectin and

mebendazole cancer paper to date and found that

ivermectin and mebendazole attack cancer

37 different ways across 25 different

human cancer types. We synthesized decades of

evidence across hundreds of studies and revealed that

ivermectin and mebendazole, these antiparasitics,

literally have some of the,

one of the broadest repertoires of anticancer

mechanisms ever documented. Ivermectin and

mebendazole basically target every major

hallmark of cancer biology. It's no wonder our previous

study on these antiparasitics found that 84%

of cancer patients saw their tumors and cancers

either disappear, shrink, or stop spreading.

Now, in our latest study, these are all of the cancers.

These are all of the human cancer types that ivermectin and mebendazole

have documented anticancer activity against

in the experimental preclinical and animal studies.

This is literally 25 different cancer types.

Um, mul- like, the, it's basically every cancer type

that ivermectin and mebendazole have anticancer activity

against. And so now we go back to the mechanisms,

'cause this is the most

important part. So it has immune system effects.

It literally activates immune cells, recruits T-cells

to basically go and attack tumors.

It literally causes DNA damage. These compounds cause DNA

damage in specifically cancer cells and

impairs cancer cell DNA repair. It also affects

cancer cell metabolism. It impairs their mitochondrial

function in cancer cells. It inhibits glycolysis, so the

cancer cells can't take up sugar as easily to grow.

It interferes with resistance and dissemination of

cancer cells, so basically it attacks cancer stem cells,

the

source of a lot of these cancers, and suppresses new

cancer cell blood vessel growth. So it stops what's

called angiogenesis. It inhibits the

microtubule cytoskeleton on cancer cells.

And lastly, signaling and transcription.

So it literally inhibits cancer cell signaling,

resulting in cell cycle arrest and

apoptosis, ce- uh, self-programmed cell

death in cancer cells. This data can no longer be

ignored by oncologists. They cannot fire their own

cancer patients anymore for seeking these antiparasitics.

The evidence is simply too strong